Mereo BioPharma Announces Interim Financial Results for the Six Months Ended June 30, 2020 and Provides Corporate Update

NEXT STORY
Black Diamond Therapeutics Announces the Appointment of Biopharmaceutical Veteran Robert A. Ingram as Chairman of the Board
PREV STORY
Affimed to Present at Jefferies Virtual Cell Therapy Summit
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Agricultural Adjuvants Market Worth $4.7 Billion by 2027 – Market Size, Share, Forecasts, and Trends Analysis Report with COVID-19 Impact by Meticulous Research®

author_avatar
NASDAQ Market News

MATEON ANNOUNCES POSITIVE INTERIM RESULTS FROM ARTI-19 CLINICAL TRIAL EVALUATING COVID-19 THERAPEUTIC

author_avatar
NASDAQ Market News

Innovest Global, Inc. Ready to Enter Healthcare Sector, As Global Health Spending Projected to Reach $8.7 Trillion By 2020 – Spotlight Growth

author_avatar
NASDAQ Market News